“…At this moment, there is no therapy considered the gold standard for this rare disease. Therapeutic alternatives are: - antibiotic therapy using agents that interact directly with the macrophages, like the quinolones or trimethoprim-sulfamethoxazole
- diminution or even suspension of the doses prescribed for the immunosuppressive therapy
- a good control of the associated immunosuppressive pathology
- endoscopic resections for the cases with localized lesions
- surgical resection for the cases that present multiple organ infiltration and or suspected malignancy [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 ].
…”